Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,270 JPY | -1.09% | -1.39% | -9.80% |
Sales 2024 * | 509B 3.27B | Sales 2025 * | 482B 3.1B | Capitalization | 1,066B 6.85B |
---|---|---|---|---|---|
Net income 2024 * | 132B 846M | Net income 2025 * | 110B 709M | EV / Sales 2024 * | 1.79 x |
Net cash position 2024 * | 157B 1.01B | Net cash position 2025 * | 220B 1.42B | EV / Sales 2025 * | 1.75 x |
P/E ratio 2024 * |
8.26
x | P/E ratio 2025 * |
9.79
x | Employees | 3,761 |
Yield 2024 * |
3.52% | Yield 2025 * |
3.57% | Free-Float | 75.82% |
Latest transcript on Ono Pharmaceutical Co., Ltd.
1 day | -1.09% | ||
1 week | -1.39% | ||
Current month | -7.54% | ||
1 month | -9.11% | ||
3 months | -13.38% | ||
6 months | -12.58% | ||
Current year | -9.80% |
Managers | Title | Age | Since |
---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 65 | 83-03-31 |
Toichi Takino
PSD | President | 55 | - |
Director/Board Member | 64 | 85-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Isao Ono
BRD | Director/Board Member | 65 | 81-03-31 |
Shusaku Nagae
BRD | Director/Board Member | 74 | - |
Gyo Sagara
CEO | Chief Executive Officer | 65 | 83-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.23% | 15 M€ | +5.53% | ||
0.67% | 251 M€ | +13.17% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2,270 | -1.09% | 1,863,000 |
24-04-24 | 2,294 | +0.17% | 2,300,000 |
24-04-23 | 2,290 | -0.09% | 1,838,400 |
24-04-22 | 2,292 | +2.44% | 2,350,100 |
24-04-19 | 2,238 | -2.76% | 2,424,800 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.80% | 6.95B | |
+18.59% | 22.25B | |
+13.49% | 14.39B | |
+12.83% | 13.55B | |
+38.02% | 11.27B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.01B | |
-5.36% | 4.51B | |
+2.40% | 4.51B |
- Stock Market
- Equities
- 4528 Stock